Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1 1

Status

Recruiting 19Completed 7Active not recruiting 4Not yet recruiting 3Enrolling by invitation 1Available 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Gastrointestinal 3

Conditions

Breast Neoplasms 159Neoplasms 116Carcinoma, Non-Small-Cell Lung 91Colorectal Neoplasms 86Prostatic Neoplasms 85Lung Neoplasms 78Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 52Pancreatic Neoplasms 46Neoplasm Metastasis 44Multiple Myeloma 38Recurrence 35Triple Negative Breast Neoplasms 31Squamous Cell Carcinoma of Head and Neck 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Ovarian Neoplasms 29Melanoma 28Uterine Cervical Neoplasms 27Stomach Neoplasms 27Glioblastoma 27Brain Neoplasms 27Rectal Neoplasms 25Head and Neck Neoplasms 25Small Cell Lung Carcinoma 23Carcinoma, Renal Cell 23Endometrial Neoplasms 20Lymphoma, B-Cell 19Glioma 19Sarcoma 18Lymphoma, Follicular 18

Interventions

regorafenib 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Gastrointestinal Stromal Tumors × 90 days × Clear all
NCT07618377 2026-06-01

Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments

Ono Pharmaceutical Co., Ltd.

Phase 1 Not yet recruiting
10 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07585266 2026-05-13

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

GlaxoSmithKline

Phase 3 Not yet recruiting
800 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07379047 2026-04-24

GISTAR-1

Ningbo Newbay Technology Development Co., Ltd

Phase 2/3 Not yet recruiting
255 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡